Indian drug companies launch cheaper GLP-1s

• By Alex Cooke

Generics flooded the market after Novo Nordisk’s patent expired on Friday (Shutterstock) Share current article via EmailShare current article via FacebookShare current article via PinterestShare current article via TwitterShare current article via LinkedIn